REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Dec 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-12-08

Reporting Person: MURPHY ANDREW J (EVP Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-08	Common Stock	A	3462	$0.0	Acquired	59167	Direct
2021-12-09	Common Stock	M	16500	$52.03	Acquired	75667	Direct
2021-12-09	Common Stock	F	9378	$657.11	Disposed	66289	Direct
2021-12-10	Common Stock	S	399	$657.61	Disposed	65890	Direct
2021-12-10	Common Stock	S	330	$658.78	Disposed	65560	Direct
2021-12-10	Common Stock	S	370	$659.29	Disposed	65190	Direct
2021-12-10	Common Stock	S	4	$660.45	Disposed	65186	Direct
2021-12-10	Common Stock	S	282	$661.57	Disposed	64904	Direct
2021-12-10	Common Stock	S	354	$662.36	Disposed	64550	Direct
2021-12-10	Common Stock	S	272	$663.61	Disposed	64278	Direct
2021-12-10	Common Stock	S	158	$664.28	Disposed	64120	Direct
2021-12-10	Common Stock	S	404	$665.29	Disposed	63716	Direct
2021-12-10	Common Stock	S	384	$666.4	Disposed	63332	Direct
2021-12-10	Common Stock	S	280	$667.5	Disposed	63052	Direct
2021-12-10	Common Stock	S	1738	$668.42	Disposed	61314	Direct
2021-12-10	Common Stock	S	1018	$669.6	Disposed	60296	Direct
2021-12-10	Common Stock	S	872	$670.68	Disposed	59424	Direct
2021-12-10	Common Stock	S	219	$671.33	Disposed	59205	Direct
2021-12-10	Common Stock	S	38	$672.3	Disposed	59167	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Non-Qualified Stock Option (right to buy)	$52.03	M	16500	Disposed	2021-12-16	Common Stock (16500)	Direct
2021-12-08	Non-Qualified Stock Option (right to buy)	$644.54	A	14783	Acquired	2031-12-08	Common Stock (14783)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4269	Indirect

Footnotes

F1: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

F2: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3: Represents volume-weighted average price of sales of 399 shares of Company stock on December 10, 2021 at prices ranging from $657.27 to $657.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 330 shares of Company stock on December 10, 2021 at prices ranging from $658.02 to $658.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 370 shares of Company stock on December 10, 2021 at prices ranging from $659.29 to $659.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $660.38 to $660.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 282 shares of Company stock on December 10, 2021 at prices ranging from $661.27 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 354 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 272 shares of Company stock on December 10, 2021 at prices ranging from $663.14 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 158 shares of Company stock on December 10, 2021 at prices ranging from $664.06 to $664.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 404 shares of Company stock on December 10, 2021 at prices ranging from $665.03 to $665.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 384 shares of Company stock on December 10, 2021 at prices ranging from $666.06 to $666.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 280 shares of Company stock on December 10, 2021 at prices ranging from $667.01 to $667.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F14: Represents volume-weighted average price of sales of 1,738 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F15: Represents volume-weighted average price of sales of 1,018 shares of Company stock on December 10, 2021 at prices ranging from $669.03 to $669.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F16: Represents volume-weighted average price of sales of 872 shares of Company stock on December 10, 2021 at prices ranging from $670.11 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F17: Represents volume-weighted average price of sales of 219 shares of Company stock on December 10, 2021 at prices ranging from $671.19 to $671.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F18: The stock option award vests in four equal annual installments, commencing one year after the date of grant.